The company has demonstrably improved the progress of an novel therapy for amyloid heart disease, leveraging Attruby. Preliminary patient results reveals promising improvements for those suffering from this severe https://attrcm099427.blogdigy.com/bridgebio-improves-amyloidosis-management-using-attruby-68366428